Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Serko Limited Director's Dealing 2023

Jul 7, 2023

66271_rns_2023-07-07_cd55d693-413c-4a54-9595-feabe7fc9a68.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [98 x 24] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer: Serko Limited
Date this disclosure made: 7-Jul-23
Date of last disclosure: 6-Mar-23
Director or senior managergivingdisclosure
Full name(s): Claudia Batten
Name of listed issuer: Serko Limited
Name of related bodycorporate(if applicable): Not applicable
Position held in listed issuer: Director
Summary of acquisition or disposal of relevant interest(excluding specified derivatives)
Class of affectedquoted financialproducts: Ordinaryshares
Nature of the affected relevant interest(s): Beneficial owner of ordinary shares held
in custody for Claudia Batten pursuant
to a Non-Executive Director Fixed
Trading Plan ("Plan").
For that relevant interest-
Number held in class before acquisition or disposal: 42,051.91(to 2dp)
Number held in class after acquisition or disposal: 41,923.06(to 2dp)
Current registered holder(s): Custodial Services Limited as custodian
for Claudia Batten
Registered holder(s)once transfers are registered: Unknown
Details of transactionsgiving rise to acquisition or disposal
Total number of transactions to which notice relates: 1
Details of transactions requiring disclosure-
Date of transaction: 4-Jul-23
Nature of transaction: On market automated sale by the
custodian under the Plan to settle
administration fees arising in relation to
the administration and management of
the Plan.
Name of anyotherpartyorparties to the transaction(if known): Unknown
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or
disposal. If the consideration was not in cash and cannot be readily by converted into a cash
value, describe the consideration:
$498.65 ($3.87/share) (to 2dp)
Number of financialproducts to which the transaction related: 128.85
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period) include
the following details—
Whether relevant interests were acquired or disposed of duringa closedperiod: Not applicable
Whether prior written clearance was provided to allow the acquisition or disposal to proceed
during the closed period:
Not applicable
Date of theprior written clearance(if any): Not applicable
Summary of other relevant interests after acquisition or disposal:
Class ofquoted financialproducts: Ordinaryshares
Nature of relevant interest: Registered holder and beneficial owner
_For that relevant interest,- _
Number held in class: 83,454
Current registered holder(s): Claudia Batten
For a derivative relevant interest,-
Type of derivative: Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any):
Not applicable
A statement as to whether the derivative is cash settled orphysicallysettled: Not applicable
Maturitydate of the derivative(if any): Not applicable
Expirydate of the derivative(if any): Not applicable
Theprice's specified terms(if any): Not applicable
Any other details needed to understand how the amount of the consideration payable under
the derivative or the value of the derivative is affected by the value of the underlying
financial products:
Not applicable
_For that derivative relevant interest,- _

Parties to the derivative: Not applicable If the director or senior manager is not a party to the derivative, the nature of the relevant Not applicable interest in the derivative: Certification I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: 7-Jul-23